Ngenla Interactions
There are 437 drugs known to interact with Ngenla (somatrogon), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 4 are major, 417 are moderate, and 16 are minor.
- View all 437 medications that may interact with Ngenla
- View Ngenla alcohol/food interactions (2)
- View Ngenla disease interactions (8)
Most frequently checked interactions
View interaction reports for Ngenla (somatrogon) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alhemo (concizumab)
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- Andembry (garadacimab)
- apremilast
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blenrep (belantamab mafodotin)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
Ngenla alcohol/food interactions
There are 2 alcohol/food interactions with Ngenla (somatrogon).
Ngenla disease interactions
There are 8 disease interactions with Ngenla (somatrogon) which include:
- active malignancy
- acute critical illness
- diabetic retinopathy
- Prader-Willi Syndrome
- intracranial hypertension
- scoliosis
- diabetes mellitus
- Turner syndrome
Report options
More about Ngenla (somatrogon)
- Ngenla consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: growth hormones
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Humatrope
Humatrope injection (somatropin) is a human growth hormone used to treat growth failure in children ...
Sogroya
Sogroya information from Drugs.com, includes Sogroya side effects, interactions and indications.
Skytrofa
Skytrofa injection is a once-weekly, slow-release human growth hormone (lonapegsomatropin) ...
Genotropin
Genotropin is a human growth hormone used to treat growth failure in children and adults who lack ...
Norditropin
Norditropin is used to treat growth hormone deficiency (GHD) in adults and children and other ...
Omnitrope
Omnitrope (somatropin) is a form of human growth hormone used to treat adults and children with ...
Norditropin FlexPro
Norditropin FlexPro is used for adult human growth hormone deficiency, idiopathic short stature ...
Zomacton
Zomacton is used for adult human growth hormone deficiency, idiopathic short stature, pediatric ...
Somapacitan-beco
Somapacitan-beco is used for adult human growth hormone deficiency, pediatric growth hormone deficiency
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
